GSEA revealed that the innate immune response and positive regulation of the interferon-beta production pathway were enriched in Trim6 KO MTC tumors (Fig. 3j-k, Supplementary Fig. 4b-c). Here, TRIM6 is linked to medullary thyroid gland carcinoma.